• In August 2026, Synchrony Financial announced a new integration with Stripe that lets U.S. health and wellness providers offer CareCredit financing directly within Stripe’s online checkout, including standard card transactions and six‑month promotional financing options.
• A key implication is that more than 12 million existing CareCredit cardholders and new applicants can now access financing through a wider range of Stripe-based health and wellness providers, without extra integrations for those providers.
• We’ll now examine how embedding CareCredit inside Stripe’s platform may influence Synchrony’s investment narrative around digital, embedded finance growth.

Invest in the nuclear renaissance through our list of 90 elite nuclear energy infrastructure plays powering the global AI revolution.

Synchrony Financial Investment Narrative Recap

To own Synchrony, you need to believe its co‑brand cards and CareCredit platform can keep generating solid profits even as digital payments and embedded finance reshape how people borrow. The Stripe integration reinforces the near term growth catalyst in health and wellness financing but does not remove key risks around concentrated retail partnerships, elevated bad loans and rising competition from fintech and alternative payment options.

Among recent moves, the April 2026 integration of Synchrony financing into Adobe Commerce stands out as closely related to the Stripe news, since both pull Synchrony further into embedded online checkout. Together, these integrations connect Synchrony to more ecommerce and health and wellness spending, which supports the catalyst of expanding digital and point of sale financing, while also increasing exposure to credit cycle and regulatory risks around consumer lending online.

Yet this push into embedded finance also raises a risk that investors should be aware of if consumer credit trends worsen and...

Synchrony Financial's narrative projects $16.6 billion revenue and $3.0 billion earnings by 2029. This requires 18.9% yearly revenue growth and a $0.5 billion earnings decrease from $3.5 billion today.

Uncover how Synchrony Financial's forecasts yield a $89.22 fair value, a 12% upside to its current price.

Exploring Other Perspectives

Some of the lowest estimate analysts tell a more pessimistic story, assuming revenue climbs to about US$17.1 billion while margins almost halve, which contrasts with the embedded finance growth narrative that underpins the Stripe news and shows how differently you might weigh the same risks and opportunities.

Explore 6 other fair value estimates on Synchrony Financial - why the stock might be worth just $78.00!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Synchrony Financial research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Synchrony Financial research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Synchrony Financial's overall financial health at a glance.

Seeking Other Investments?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• This technology could replace computers: discover 25 stocks that are working to make quantum computing a reality.
• The future of work is here. Discover the 39 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• We've uncovered the 9 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.